Oncorus' Series A - IV Round

Oncorus raised a round of funding on September 21, 2018.

Oncorus is a pre-clinical stage biotechnology company developing oncolytic HSV products with the potential to recruit all arms of immune system to treat solid tumors.…

Articles about Oncorus' Series A - IV Round: